Product Information
MEDROXYPROGESTERONE 2.5 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1156 per EA under NDC 00555087204. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 9, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555087204
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA040159FDA Approved
8/9/1996
TE Code
AB
On Market Since
12/4/1996
Pharmacological Classes
Price Statistics
The NADAC for MEDROXYPROGESTERONE 2.5 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 91.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1156 per EA |
|---|---|
| All-time high | $0.1312 (Mar 11, 2015) |
| All-time low | $0.0591 (Jan 22, 2014) |
| 52-week high | $0.1196 |
| 52-week low | $0.1141 |
| Median price | $0.1093 |
| Average price | $0.1096 |
| Largest weekly change | +59.3% (Jun 18, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Medroxyprogesterone Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEDROXYPROGESTERONE 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 2.5 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.1156 per EA (NDC 00555087204), effective Sep 30, 2026.
How has the price of MEDROXYPROGESTERONE 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 2.5 MG TAB has risen 91.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 2.5 MG TAB?
Since Nov 28, 2013, the NADAC for MEDROXYPROGESTERONE 2.5 MG TAB has ranged from a low of $0.0591 (Jan 22, 2014) to a high of $0.1312 (Mar 11, 2015), with a median of $0.1093 per EA.
Are there cheaper alternatives to MEDROXYPROGESTERONE 2.5 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEDROXYPROGESTERONE 2.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures MEDROXYPROGESTERONE 2.5 MG TAB?
MEDROXYPROGESTERONE 2.5 MG TAB (NDC 00555087204) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.